LAURA BOTHE: Open Payments
NPI 1396393955 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 17 payments from 7 companies in 2025. Trend: 2023 $57 · 2024 $63 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $191 |
| Lilly USA, LLC | 4 | $90 |
| PFIZER INC. | 4 | $72 |
| ABBVIE INC. | 1 | $35 |
| Exact Sciences Corporation | 1 | $31 |
| Philips North America LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: Ozempic, MOUNJARO, PREVNAR 20, QULIPTA, The Cologuard Plus Collection Kit, Ambulatory Monitoring & Diagnostics Undivided, Kerendia, PAXLOVID.
Industry payments across MD — which companies pay providers there.
